当前位置:首页 - 行情中心 - 亿帆医药(002019) - 财务分析 - 资产负债表

亿帆医药

(002019)

  

流通市值:93.20亿  总市值:134.25亿
流通股本:8.51亿   总股本:12.26亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金744,397,403.77879,237,410.961,214,966,438.531,143,783,700.15
应收票据及应收账款1,026,037,672.831,068,262,766.761,078,207,996.21,182,828,833.36
其中:应收票据760,000993,627.23898,627.231,468,627.23
应收账款1,025,277,672.831,067,269,139.531,077,309,368.971,181,360,206.13
应收款项融资115,222,187.6277,270,721.5481,569,991.7175,057,736.41
预付款项126,626,402.54146,203,570.15142,199,471.5158,373,572.84
其他应收款合计106,327,315.49111,228,658.87110,814,610.89111,002,283.09
存货985,049,780.02979,718,209.98934,754,655.18830,971,366.16
一年内到期的非流动资产1,139,348.251,139,348.251,047,930.621,075,867.87
其他流动资产102,955,823.2798,950,285.72106,930,024.5591,331,872.86
流动资产平衡项目0000
流动资产合计3,282,755,933.793,532,010,972.233,685,491,119.183,689,927,463.47
非流动资产:
长期应收款1,602,678.971,855,202.111,932,050.392,163,994.4
长期股权投资688,008,003.63718,008,147.34671,382,882.73681,684,840.73
其他权益工具投资15,000,00015,000,00015,000,00015,000,000
投资性房地产36,966,169.2137,363,157.437,957,600.5638,355,964.82
固定资产1,341,685,019.561,359,268,048.381,370,453,291.971,340,721,820.36
在建工程212,798,346.23173,909,310.2137,830,230.33175,798,958.09
使用权资产75,261,385.0981,964,868.2786,270,767.284,862,699.22
无形资产1,083,223,121.91,105,579,741.88748,727,495.52751,372,184.43
开发支出2,384,971,265.692,354,151,917.932,604,377,750.672,547,370,269.88
商誉2,737,766,723.372,737,766,723.372,737,766,723.372,737,766,723.37
长期待摊费用44,240,663.7644,872,615.1946,117,473.3744,661,752.11
递延所得税资产317,284,948.07309,210,650.84305,432,335.88290,797,553.59
其他非流动资产125,377,209.75109,196,235.39140,122,521.14143,019,191.59
非流动资产平衡项目0000
非流动资产合计9,064,185,535.239,048,146,618.38,903,371,123.138,853,575,952.59
资产平衡项目0000
资产总计12,346,941,469.0212,580,157,590.5312,588,862,242.3112,543,503,416.06
流动负债:
短期借款526,443,497.05662,420,140.86810,426,926.78659,259,838.41
应付票据及应付账款318,161,373.05328,660,033.24318,722,641.33288,402,707.69
其中:应付票据--518,875.14-
应付账款318,161,373.05328,660,033.24318,203,766.19288,402,707.69
预收款项877,117.481,587,822.43375,294.871,295,935.24
合同负债150,020,820.39144,822,660.34112,555,545.67201,966,799.73
应付职工薪酬120,180,155.66112,360,262.42117,339,267.41142,129,165.85
应交税费64,782,186.5460,658,003.7159,748,168.23107,461,620.84
其他应付款合计234,442,915.69252,251,788222,147,045.53207,402,366.27
应付股利1,592,500---
一年内到期的非流动负债598,145,555.36494,297,393.71430,410,047.86571,978,927.35
其他流动负债9,273,373.067,797,364.338,769,047.5919,505,267.16
流动负债平衡项目0000
流动负债合计2,022,326,994.282,064,855,469.042,080,493,985.272,199,402,628.54
非流动负债:
长期借款732,565,535889,942,101.33995,414,464.31850,167,815.9
租赁负债68,004,626.875,750,987.9981,104,309.3580,694,048.73
长期应付职工薪酬20,011,392.0820,187,701.0419,614,145.8318,938,251.13
预计负债4,041,443.383,565,969.083,003,034.532,449,153.34
递延收益97,255,771.32102,675,877.9103,912,169.95104,840,627.3
递延所得税负债136,432,899.16137,781,630.92139,540,810.1140,767,230.69
非流动负债平衡项目0000
非流动负债合计1,058,311,667.741,229,904,268.261,342,588,934.071,197,857,127.09
负债平衡项目0000
负债合计3,080,638,662.023,294,759,737.33,423,082,919.343,397,259,755.63
所有者权益(或股东权益):
实收资本(或股本)1,046,318,444.681,046,318,444.681,046,318,444.681,046,318,444.68
资本公积2,992,852,296.962,992,852,296.962,992,852,296.962,992,852,296.96
减:库存股121,005,048.45121,005,048.45121,005,048.45121,005,048.45
其他综合收益-32,014,678.53,040,745.62-74,199,582.89-57,091,465.59
专项储备47,934,816.9247,185,230.0646,063,710.0945,735,332.81
盈余公积150,075,000150,075,000150,075,000150,075,000
未分配利润4,901,445,644.814,863,260,381.344,819,374,422.794,754,599,994.59
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计8,985,606,476.428,981,727,050.218,859,479,243.188,811,484,555
少数股东权益280,696,330.58303,670,803.02306,300,079.79334,759,105.43
股东权益平衡项目0000
股东权益合计9,266,302,8079,285,397,853.239,165,779,322.979,146,243,660.43
负债和股东权益合计12,346,941,469.0212,580,157,590.5312,588,862,242.3112,543,503,416.06
公告日期2023-10-312023-08-302023-04-292023-04-15
审计意见(境内)标准无保留意见
TOP↑